Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (12,926,350)	$ (11,679,154)
Adjustments to reconcile net loss from operations to net cash used in operating activities:
Depreciation	3,950,932	3,829,345
Depreciation - discontinued operations		1,723,611
Amortization of intangible assets	324,190	189,329
Allowance for doubtful accounts	6,473,838	2,756,411
Allowance for doubtful accounts - discontinued operations	66,085
Loss from impairment of acquisition of a non-wholly owned subsidiary	462,111
Loss on sale of subsidiary of discontinued operations		6,459,407
Loss from impairment of property and equipment - discontinued operations		1,660,305
Loss on equity method investment	130,498
Stock-based compensation and fees	1,586,643	927,206
Inventory reserve	285,334
Changes in operating assets and liabilities:
Notes receivable	(306,542)	(10,537)
Accounts receivable	(924,212)	(5,906,749)
Inventories	(2,209,520)	(874,055)
Prepaid and other current assets	(255,321)	6,070
Advances to suppliers	(801,282)	(742,745)
Deferred tax assets	397,014	(188,090)
Assets of discontinued operations	42,273	2,659,512
Accounts payable	1,849,047	(958,163)
Accrued expenses	(210,396)	(173,030)
VAT and service taxes payable	(48,621)	(132,933)
Income taxes payable	(20,532)	(170,936)
Advances from customers	1,923,909	52,341
Liabilities of discontinued operations	(198,889)	(6,375,676)
Net cash used in operating activities	(409,791)	(6,948,531)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of patent use rights		(2,408,369)
Purchase of property and equipment	(5,199,833)	(1,209,477)
Payments made for equity method investment		(9,001,279)
Proceed received from sale of subsidiary in cash	2,130,556	2,167,532
Proceeds from sales of equipment from discontinued operations	1,146,959
Net cash used in investing activities	(1,922,318)	(10,451,593)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from bank loans	1,257,620	3,763,077
Repayments of bank loans	(1,479,553)	(3,838,338)
Proceeds from convertible note payable	670,000
Decrease in restricted cash	303,308	60,209
Increase in restricted cash - discontinued operations		(67,735)
Decrease in bank acceptance notes payable	(155,353)	(60,209)
Advance from related party	347,589
Proceeds from sale of common stock, net	860,000	753,400
Net cash provided by financing activities	1,803,611	610,404
Effect of exchange rate changes on cash and cash equivalents	66,437	(519,152)
Net decrease in cash and cash equivalents	(462,061)	(17,308,872)
Cash and cash equivalents - beginning of year	1,481,498	18,790,370
Cash and cash equivalents - end of year	1,019,437	1,481,498
Cash paid in continuing operations for:
Interest	134,459	166,935
Income taxes		360,318
Cash paid in discontinued operations for:
Interest		48,250
Income taxes		189,570
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock issued for future services	1,709,989	9,074
Stock issued for accrued liabilities	37,835	54,000
Stock issued for acquisition of a non-wholly owned subsidiary	507,710
Property and equipment acquired on credit as payable		15,263
Decrease in assets upon sale of subsidiary		14,673,414
Decrease in liabilities upon sale of subsidiary		1,012,452
Increase in receivable from sale of subsidiary		$ 7,225,107